B. Oyan Et Al. , "Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-hodgkin lymphoma: A salvage regimen with high response rates before autologous stem cell transplantation," BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , vol.11, no.9, pp.688-697, 2005
Oyan, B. Et Al. 2005. Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-hodgkin lymphoma: A salvage regimen with high response rates before autologous stem cell transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , vol.11, no.9 , 688-697.
Oyan, B., Koc, Y., Ozdemir, E., Kars, A., Turker, A., Tekuzman, G., ... Kansu, E.(2005). Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-hodgkin lymphoma: A salvage regimen with high response rates before autologous stem cell transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , vol.11, no.9, 688-697.
Oyan, BAŞAK Et Al. "Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-hodgkin lymphoma: A salvage regimen with high response rates before autologous stem cell transplantation," BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , vol.11, no.9, 688-697, 2005
Oyan, BAŞAK O. Et Al. "Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-hodgkin lymphoma: A salvage regimen with high response rates before autologous stem cell transplantation." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , vol.11, no.9, pp.688-697, 2005
Oyan, B. Et Al. (2005) . "Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-hodgkin lymphoma: A salvage regimen with high response rates before autologous stem cell transplantation." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , vol.11, no.9, pp.688-697.
@article{article, author={BAŞAK OYAN ULUÇ Et Al. }, title={Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-hodgkin lymphoma: A salvage regimen with high response rates before autologous stem cell transplantation}, journal={BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION}, year=2005, pages={688-697} }